Oncotarget is a publication owned by Mikhail Blagosklonny and Andrei Gudkov, two of the most prominent oncologists who are working for the Roswell Park Cancer Institute. The two are good friends, and they have been working on their project for several years now. Oncotarget is considered as the only peer-reviewed online medical journal, which allows them to screen and critic every article that is being sent to the company. Because of the inquiry coming from the public asking for the direction on how they can write for the online medical journal, Oncotarget decided to make all of their communication lines available for public use. Learn more about Oncotarget at Research Gate.
This year, Oncotarget will be sending some of the researchers who are also working as a contributor for Oncotarget. The representatives were chosen according to their performance with the government, and they are hoping that the company would continue to rise against its competitors. Since the magazine’s official debut in 2010, more and more people are becoming interested in what Oncotarget is. For those people who wanted to learn something new, all they have to do is to visit the website of Oncotarget and choose the options available all throughout the screen. The official website of Oncotarget can be compared to a giant library where all the books have been restored and placed in their right places. The articles written on the website of Oncotarget shows how cooperation is slowly changing the scientists’ perception about cancer. Download output styles at Endnote.com
— Oncotarget (@OncotargetJrnl) December 12, 2017
Today, Oncotarget is being released twice a week. The contributors can write as many as they wanted, but only a few will be accepted and posted on their original website. For those who wanted to join the growing number of people who are affiliated with Oncotarget, all they have to do is to visit the site and send an email of inquiry. There will be further actions to those who would like to write for the scientific journal.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/